Influenza B virus replication machinery (IBV replication)

Influenza B virus replication refers to the complex biological process by which the virus duplicates its genetic material and produces new virions within a host cell. This process is driven primarily by the viral RNA-dependent RNA polymerase (RdRp) complex, consisting of the PA, PB1, and PB2 subunits, along with the viral nucleoprotein (NP). The machinery is responsible for both the transcription of viral mRNA and the replication of the negative-sense RNA genome. Because these enzymes are essential for the viral life cycle and lack human homologs, they are primary targets for antiviral drug development. Drugs like Baloxavir marboxil target the endonuclease activity of the polymerase to halt viral protein production, while others act as nucleoside analogs to terminate RNA chain elongation. This entry is marked as incorrect because 'replication' is a multi-step biological process rather than a single molecular target; therapeutic intervention typically targets specific proteins within this pathway, such as the Influenza B virus polymerase complex.

Other names

Influenza B virus replicationInfluenza B polymerase complexInfluenza B viral RNA synthesis

Inhibition of the viral RNA-dependent RNA polymerase (RdRp) complex, specifically targeting the cap-dependent endonuclease activity (PA subunit) or acting as a chain terminator during RNA synthesis.